Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|September 15, 2020
Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus StatementAhizechukwu C Eke, Adeniyi Olagunju, Jeremiah Momper, et al.
The Lancet. HIV|December 9, 2021
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation studyAdrie Bekker, Edmund V Capparelli, Avy Violari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2021
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic StudyPaolo Denti, Roeland E Wasmann, Annelies van Rie, et al.
Eclinicalmedicine|March 1, 2024
Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trialNeal Russell, Michelle N Clements, Kazi Shammin Azmery, et al.
The Lancet. HIV|July 21, 2022
Advancing the prevention and treatment of HIV in children: priorities for research and developmentMartina Penazzato, Claire L Townsend, Nadia A Sam-Agudu, et al.
The Lancet. Child & Adolescent Health|March 24, 2024
Management of the infant born to a mother with tuberculosis: a systematic review and consensus practice guidelineNadia Hasan, Clare Nourse, H Simon Schaaf, et al.
The Lancet. HIV|October 11, 2025
Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trialAdrie Bekker, Nicolas Salvadori, Helena Rabie, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026sMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2025
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s studyMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
Bulletin of the World Health Organization|December 2, 2025
Target product profiles for paediatric formulations of azithromycin and nitrofurantoinYasir Bin Nisar, Giulia Brigadoi, Shabina Ariff, et al.
Pageof 9